Concord Medical Co., Ltd. (TPEX:6518)
Taiwan
· Delayed Price · Currency is TWD 26.60
0.00 (0.00%)
Mar 9, 2026, 2:31 PM CST
Concord Medical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 54.73 | 49.57 | 42.74 | 50.66 | 34.4 | 19.77 | Upgrade
|
| Depreciation & Amortization | 85.13 | 84.58 | 78.61 | 75.99 | 96.25 | 102.88 | Upgrade
|
| Other Amortization | 1.65 | 1.63 | 0.82 | 0.43 | 0.34 | 0.32 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.33 | -0.15 | -0.41 | -1.69 | -9.16 | -1.85 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.22 | 1.02 | 0.17 | -0.69 | -1.84 | -0.13 | Upgrade
|
| Other Operating Activities | 1.99 | 3.35 | -5.33 | 3.91 | 3.63 | -2.84 | Upgrade
|
| Change in Accounts Receivable | 39.74 | 4.45 | 9.48 | -2.72 | 6.64 | -19.21 | Upgrade
|
| Change in Inventory | 0.11 | -1.43 | 2.02 | 3.18 | -6.53 | 0.79 | Upgrade
|
| Change in Accounts Payable | -3.2 | 4.32 | -15.14 | 17.83 | 0.67 | 15.41 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | - | -0.45 | Upgrade
|
| Change in Other Net Operating Assets | 7.09 | 1.48 | 0.26 | 7.66 | 13.02 | -30.66 | Upgrade
|
| Operating Cash Flow | 186.69 | 148.83 | 113.23 | 154.56 | 137.42 | 84.07 | Upgrade
|
| Operating Cash Flow Growth | 66.26% | 31.45% | -26.74% | 12.47% | 63.47% | -35.86% | Upgrade
|
| Capital Expenditures | -73.88 | -74.72 | -88.18 | -37.46 | -21.8 | -93.64 | Upgrade
|
| Sale of Property, Plant & Equipment | 3.71 | 3.16 | 4.47 | 19.84 | 30.88 | 35.41 | Upgrade
|
| Sale (Purchase) of Intangibles | -1.81 | -1.65 | -1.51 | -0.61 | 24.19 | -0.39 | Upgrade
|
| Investment in Securities | -11.7 | -22.5 | -109 | -97.23 | - | 2.59 | Upgrade
|
| Other Investing Activities | 3.42 | 3.38 | 6.14 | 5.15 | -0.1 | 1.18 | Upgrade
|
| Investing Cash Flow | -79.72 | -92.33 | -188.08 | -110.31 | 33.17 | -54.86 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 67.86 | Upgrade
|
| Long-Term Debt Issued | - | - | 35 | - | - | 0.02 | Upgrade
|
| Total Debt Issued | 40.5 | - | 35 | - | - | 67.88 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -76.36 | Upgrade
|
| Long-Term Debt Repaid | - | -24.69 | -22.11 | -19.58 | -120.69 | -27.98 | Upgrade
|
| Total Debt Repaid | -27.34 | -24.69 | -22.11 | -19.58 | -120.69 | -104.33 | Upgrade
|
| Net Debt Issued (Repaid) | 13.16 | -24.69 | 12.89 | -19.58 | -120.69 | -36.46 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 100 | - | Upgrade
|
| Common Dividends Paid | -36.67 | -33.33 | -33.33 | -16.67 | -10 | -10 | Upgrade
|
| Other Financing Activities | - | - | -40.35 | 40.11 | -0.53 | -0.06 | Upgrade
|
| Financing Cash Flow | -23.51 | -58.02 | -60.8 | 3.87 | -31.22 | -46.52 | Upgrade
|
| Net Cash Flow | 83.47 | -1.51 | -135.65 | 48.11 | 139.38 | -17.31 | Upgrade
|
| Free Cash Flow | 112.81 | 74.12 | 25.05 | 117.1 | 115.63 | -9.58 | Upgrade
|
| Free Cash Flow Growth | 115.84% | 195.91% | -78.61% | 1.27% | - | - | Upgrade
|
| Free Cash Flow Margin | 12.46% | 8.33% | 3.01% | 13.17% | 15.65% | -1.18% | Upgrade
|
| Free Cash Flow Per Share | 3.37 | 2.21 | 0.75 | 3.51 | 4.61 | -0.38 | Upgrade
|
| Cash Interest Paid | 3.5 | 3.55 | 3.52 | 3.51 | 4.79 | 6.2 | Upgrade
|
| Cash Income Tax Paid | 12.72 | 10.1 | 16.6 | 9.5 | 4.59 | 8.53 | Upgrade
|
| Levered Free Cash Flow | 94.59 | 54.59 | 16.19 | 108.82 | 121.36 | -11.7 | Upgrade
|
| Unlevered Free Cash Flow | 96.77 | 56.81 | 18.39 | 111.01 | 124.35 | -7.76 | Upgrade
|
| Change in Working Capital | 43.75 | 8.82 | -3.39 | 25.95 | 13.8 | -34.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.